Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: ...

FDA Drug Recall #D-0610-2017 — Class II — February 15, 2017

Recall Summary

Recall Number D-0610-2017
Classification Class II — Moderate risk
Date Initiated February 15, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm AVKARE Inc.
Location Pulaski, TN
Product Type Drugs
Quantity 116 cartons

Product Description

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13

Reason for Recall

Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

Distribution Pattern

Nationwide

Lot / Code Information

Lot #15152, Exp. 02/2018

Other Recalls from AVKARE Inc.

Recall # Classification Product Date
D-1329-2022 Class III Lamotrigine Tablets, USP 100 mg, 1000-count bot... Jul 20, 2022
D-0631-2021 Class III Phytonadione Tablets 5 mg, Rx Only, 30 Tablets ... Jun 9, 2021
D-0168-2021 Class I TraZODONE Hydrochloride Tablets USP 100 mg, Rx ... Dec 7, 2020
D-0167-2021 Class II Sildenafil Tablets USP 100 mg, Rx Only, 100-cou... Dec 7, 2020
D-0070-2021 Class II Mesalamine Delayed-Release Tablets, USP 1.2 gra... Oct 30, 2020

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.